General
South Africa to suspend rollout of AstraZeneca coronavirus vaccine
South Africa was set to suspend the rollout of the AstraZeneca vaccine after trial data showed the jab offered limited protection against mild disease caused by B.1.351, the coronavirus variant first identified in the country.
Key points:
- Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against the South Africa variant
- Vaccine lead researcher Sarah Gilbert said the company expected to have a new jab to cope with the variant by September
- Federal Health Minister Greg Hunt said he was not concerned about vaccine
Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against mild disease caused by the South Africa variant.
But the…
Continue Reading
-
Noosa News23 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
Noosa News13 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General8 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
General10 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for